Can a VR vacation lift depression in dialysis patients?

NCT ID NCT05642364

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a 5-week virtual reality program that teaches positive thinking skills can help reduce depression and improve quality of life in people on hemodialysis. Sixty-one adults with end-stage kidney disease and mild-to-moderate depressive symptoms will either receive the immersive VR program or a placebo VR with nature scenes. The main goals are to see if the approach is feasible and acceptable, and to gather early data on its effects on mood, treatment adherence, and hospitalizations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Virtual reality-based positive psychological intervention (Joviality™)
What this could lead to
If it works, this could offer a new, engaging way to improve emotional well-being and quality of life for people on dialysis.
What could go wrong
This is a small, early feasibility study with only 61 participants. It is designed to test whether the approach is acceptable and practical, not yet to prove it works. The control group also receives a VR experience, so any benefit may be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • DaVita Garfield Kidney Center

    Chicago, Illinois, 60624, United States

  • DaVita Little Village Dialysis PD

    Chicago, Illinois, 60608, United States

  • UI Health - Dialysis Unit, EEI Suite 2028

    Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.